documents: FDA-2020-N-0026-0028

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-0026-0028 FDA FDA-2020-N-0026 Issuance of Priority Review Voucher; Rare Pediatric Disease Product; DUVYZAT (givinostat) Notice Announcement 2024-04-11T04:00:00Z 2024 4 2024-04-11T04:00:00Z   2024-04-11T14:00:15Z 2024-07657 0 0 09000064864cd930

Links from other tables